Sentence examples for difference in the screening from inspiring English sources

There was little difference in the screening rates between urban (189.0 per 1000) and rural (186.6) areas.

This difference in the screening interval for those >10 years of age could potentially underestimate the risk, where the time to DAA seroconversion could be a year earlier than observed.

These estimates were based on different methodologies but the wide variation observed could also be explained by differences in the screening setting (opportunistic or population based with quality standards) and in the cohort of women analyzed.

These differences in the screening performance are attributable to multiple factors, such as the different selection of: (a) the protonation/tautomerization state of the target's binding site residues and molecules of the datasets, and (b) the input geometry of the prepared molecules due to the intrinsic differences between the force field parameters of both preparation schemes.

The differences in the rates of depression, anxiety and stress symptoms between our study and others may be attributed to differences in the screening or diagnostic instruments used, the socio-cultural differences of different populations and also the sample size of the subjects.

"It isn't clear exactly at which age women should begin screening," Nunn added, "which is why there are differences in the screening programmes across the UK".

Among these jurisdictions we do not consider that small differences in the screening programmes explain differences in the stage distribution or in stage-specific survival.

Such mutant pairs with discrepancy in their interaction scores may be either due to differences in the screening approaches or due to false positive findings.

Given the differences in the screening mammography rates and the time-shift of breast cancer mortality between the US and Japan, and considering that similar advanced cancer therapies are available in both countries, it is likely that screening mammography plays an important role in explaining these differences in outcomes.

We suggest that surveillance practices (a gynaecology consultation or a mammography during the years before diagnosis) as well as the circumstances of the mammography (screening or not) resulting from differences in the screening programmes in the counties may have influenced the stage at diagnosis.

As the frequency of the biomarker increases, the relative contribution of the screening costs to the overall cost per QALY gained, and, by extension, the effect of differences in the screening cost per person becomes correspondingly less (Tables 4 and 5).